期刊
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
卷 89, 期 4, 页码 1269-1274出版社
WILEY
DOI: 10.1111/bcp.15641
关键词
calcium-channel blocker; effectiveness; insulin; poisoning; safety
High-dose insulin (HDI) therapy with adapted glucose supplementation is suggested as a first-line treatment for calcium-channel blocker (CCB) poisonings. Our narrative review supports the effectiveness and safety of HDI based on published experimental studies, case reports, and experts' opinions. HDI is strongly recommended in CCB-poisoned patients with cardiovascular compromise, especially if cardiac function impairment has been diagnosed, without delaying the administration of vasopressors/inotropic drugs.
High-dose insulin (HDI) therapy with adapted glucose supplementation to maintain euglycaemia has been suggested to treat calcium-channel blocker (CCB) poisonings. Its underlying mechanisms of action are now well documented. We present a narrative review of the published experimental studies, case reports and experts' opinions to support the effectiveness and safety of HDI in the treatment of CCB poisoning. Our review strongly encourages the use of HDI as first-line therapy in CCB-poisoned patients in the presence of cardiovascular compromise, especially if cardiac function impairment has been diagnosed, before, but without delaying, the administration of vasopressors/inotropic drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据